• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

NeoChord announces positive study results from transcatheter mitral chordal repair device

October 24, 2022 By Danielle Kirsh

NeoChordNeoChord recently announced positive results from a clinical study of its transcatheter NeXuS system for mitral chordal repair.

The company’s global early feasibility study treated patients with the transcatheter NeXuS system and results at one-year follow-up demonstrated notable clinical benefit and patient physiological improvement, according to the company.

NeoChord’s study results showed a pre-procedure mitral regurgitation (MR) grade of severe (4+) was reduced to trace and remained unchanged through all follow-up intervals. The results also showed significant improvement in the left ventricular ejection fraction and left atrial dimensions.

“We are pleased to begin reporting on patient outcomes at the 1-year follow-up period. These impressive results build upon our existing body of robust clinical evidence and represent a significant milestone not only for NeoChord, but also for the treatment of mitral regurgitation. Most importantly, the study results validate the efficacy and safety of using the NeXuS System to perform multiple-chord to single anchor procedures and further establishes NeoChord’s leadership position in off-pump, beating heart mitral chordal repair,” President and CEO David Chung said in a news release.

Mitral regurgitation is one of the most common heart valve diseases that affect millions of people around the world. If the condition is left untreated, it could lead to chronic heart failure. Mitral regurgitation is characterized by blood leaking backward within the heart that is caused by ruptured native chords and the mitral valve’s inability to close properly.

NeoChord’s NeXuS transcatheter mitral chordal repair device restores function in patients with primary mitral regurgitation. It maintains the natural physiologic functionality of the mitral valve and is deployed through the vein using a transfemoral delivery catheter that is navigated transeptally to the diseased native mitral valve.

“These are compelling results for the future of minimally invasive transcatheter chordal repair, a procedure poised to drive positive outcomes and patient benefits by maintaining the physiologic construction of the mitral valve,” said Dr. Azeem Latin, section head and director of interventional cardiology and structural heart interventions at Montefiore Medical Center. “This procedure is a promising addition to the mitral toolbox and affords the heart team with an option to provide patients with an interventional approach to a surgically-proven technique.”

Filed Under: Catheters Tagged With: NeoChord

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS